| 119.86 Data as of May 10 |  +13.05 / +12.22%Today’s Change | 67.67 Today|||52-Week Range 121.13 | +39.37% Year-to-Date |
| Actavis in talks to buy Warner Chilcott May 10 / FT.com | Earnings Miss at Perrigo - Analyst Blog May 07 / Zacks.com |
| Watson Reaches New 52-Week High (WPI) May 10 / TheStreet.com | Perrigo Likely to Report In Line Earnings - Analyst Blog May 06 / Zacks.com |
| Actavis Reaches New 52-Week High (ACT) May 10 / TheStreet.com | Acorda Incurs Loss, Maintains Guidance - Analyst Blog May 06 / Zacks.com |
| Actavis: What it's like to join the Fortune 500 May 10 / Fortune | Actavis Goes Negative May 06 / MotleyFool.com |
| Did Actavis Squander Its Latest Sales Increase? May 09 / MotleyFool.com | Company News for May 3, 2013 - Corporate Summary May 03 / Zacks.com |
| Previous close | 106.81 |
| Today’s open | 107.58 |
| Day’s range | 105.56 - 121.13 |
| Volume | 8,049,692 |
| Average volume (3 months) | 1,298,134 |
| Market cap | $13.6B |
| Dividend yield | -- |
| Earnings growth (last year) | -63.11% |
| Earnings growth (this year) | +38.32% |
| Earnings growth (next 5 years) | +11.02% |
| Revenue growth (last year) | +29.02% |
| P/E ratio | NM |
| Price/Sales | 1.83 |
| Price/Book | 3.56 |
| Today’s change | Today’s % change | |
|---|---|---|
| MYLMylan Inc | +0.38 | +1.30% |
| PRGOPerrigo Co | +2.61 | +2.23% |
| ZTSZoetis Inc | -0.37 | -1.10% |
| VRTXVertex Pharmaceutica... | +3.65 | +4.75% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $2.00 |
| Annual revenue (last year) | $5.9B |
| Annual profit (last year) | $97.3M |
| Net profit margin | 1.65% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Paul M. Bisaro |
President- Global Operations Robert A. Stewart, Jr. |
Corporate headquarters Parsippany, New Jersey |
.
